Attached files
| file | filename |
|---|---|
| EX-10.1 - FORM OF STOCK OPTION AGREEMENT - BIOLOGIX HAIR INC. | f8k061813ex10i_biologix.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 18, 2013
|
BIOLOGIX HAIR INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Nevada
|
000-54882
|
27-4588540
|
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
82 Avenue Road, Toronto, Ontario, Canada
|
M5R 2H2
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code (647) 344-5900
|
n/a
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01
|
Entry into Material Definitive Agreement
|
|
Item 3.02
|
Unregistered Sales of Equity Securities
|
Effective June 18, 2013, our company granted an aggregate of 100,000 stock options to one individual of our medical advisory board of our company pursuant to our 2013 Stock Plan. The stock options are exercisable into one common share of our company for five years from the date of grant at an exercise price of $2.50 per share.
Also effective June 18, 2013, our company entered into stock option agreements with one individual of our medical advisory board in connection with granting of the stock options.
An aggregate of 100,000 stock options to one (1) non-US person (as that term is defined in Regulation S of the Securities Act of 1933) in an offshore transaction relying on Regulation S of the Securities Act of 1933, as amended.
|
Item 9.01
|
Financial Statements and Exhibits
|
|
10.1
|
Form of Stock Option Agreement
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOLOGIX HAIR INC.
|
|
|
/s/ Ronald Holland
|
|
|
Ronald Holland
|
|
|
Director
|
|
| Date: July 26, 2013 |